Porphobilinogen is excreted in the urine in large quantities in acute porphyria and is always found in the livers of fatal cases of this disease. In experimental porphyria in animals induced by sedormid (allyli8opropylacetylurea) (Schmid & Schwartz, 1952) or allyli8opropylacetamide (Goldberg, 1953) , porphobilinogen is likewise found in the urine and liver. Previous reports on the behaviour of this substance when administered to experimental animals are conflicting, probably because the porphobilinogen used was only partially purified or was available in amounts too small for adequate investigation. Thus Waldenstrom & Wendt (1939) injected partially purified porphobilinogen into rabbits and found it to be excreted in the urine, while Prunty (1945) failed to find any in the urine under similar conditions. Goldberg, Paton & Thompson (1954) injected porphobilinogen, which had been isolated by Westall (1952) , intravenously into one rabbit with an external bile fistula and found traces of uroporphyrin in the urine and a slight increase in the excretion of bile porphyrin.
The following experiments with porphobilinogen were done in order to clarify its mode of excretion in an experimental animal. It is suggested that the results of these studies in the rat may be relevant to human acute porphyria. It was found that porphobilinogen, when administered parenterally to the rat, is excreted into the urine mainly by glomerular filtration. If it is given enterally or parenterally, it is not found in the livers of rats subsequently killed, at a time when the plasma still contains porphobilinogen. These findings suggest that the porphobilinogen, found in the livers of rats with experimental porphyria, has been formed there and has not been transported to the liver from an extrahepatic site.
Falk, Dresel & Rimington (1953) showed that porphobilinogen behaved as a precursor of certain porphyrins in a haemolysed chicken-erythrocyte system. In the present work, a small but significant conversion of porphobilinogen into coproporphyrin III and uroporphyrin III has been detected in the rat. A brief preliminary communication concerning this work has appeared (Goldberg & Rimington, 1954a) .
METHODS General
The Wistar-strain rats used weighed between 150 and 214 g. with the exception of rat no. 7 which weighed 112 g. Rats nos. 9 and 13 were female. They were placed in metabolism cages. In studies lasting 2 weeks, separate daily urinary and faecal specimens were analysed every second day for porphyrins, the specimens not determined on the day of excretion being stored at 20. In experiments where urine was collected at frequent intervals, eg. half-hourly or hourly, micturition was induced bya 'tail-pulling' procedure similar to that described by Hutschenreuter (1933) . In collecting urine from metabolism cages, the cage was washed with water, until the washings were free from porphobilinogen (see below). In the experiment on rat no. 9, where hourly urine specimens were taken for 20 hr., the interior of the metabolism cage was washed 4 times at the end of each hr. with a total vol. (each hr.) of 200 ml. water. The porphobilinogen used had been isolated in the crystalline form (Westall, 1952; Cookson & Rimington, 1954) and was administered as the hydrochloride in 0-9 % (w/v) NaCl, using 0-5 ml. for parenteral injection and 1 ml.
for enteral administration. Intravenous injections were given into a tail vein, subeutaneous into the dorsal area of the rat. All enteral administration was carried out by gastric intubation as described by Goldberg & Rimington (1954b) .
Haematological values were determined as described (Goldberg, 1954) .
Isolation and determination of porphyrins
Urine. Coproporphyrin was extracted by the method of Schwartz, Zieve & Watson (1951) . Uroporphyrin from the same specimen of urine was obtained by combining the aqueous and sodium acetatewashingsfromthe coproporphyrineextraction,andbringing thesetopH3-0-3-2.Thewashings were then shaken with ethyl acetate, the aqueous layer was discarded and uroporphyrin extracted with 06N-HCI.
Faeces. Coproporphyrin and protoporphyrin were extracted by the method of Schwartz & Wikoff (1952) with the following modifications. The ethyl acetate was shaken with 20-30 ml. 0-005% aqueous I. immediately after extraction of porphyrins with 3N-HCI. The aqueous layer was discarded and a further extraction with 3N-HCl carried out, in order to obtain any porphyrin precursor. This was not found in any specimen. The final coproporphyrin extraction in 0-1 N-HCI was not shaken with CHC13. Uroporphyrin was obtained from the sodium acetate washings of the ethyl acetate layer during the above procedure. These acetate washings were dealt with in the same way as described for urinary uroporphyrin.
The porphyrins, so extracted from urine and faeces, were determined by the method of Rimington & Sveinsson (1950) using a Beckman spectrophotometer, model D.U.
Paper chromatography ofporphyrin8. This was carried out as described (Goldberg, 1954) . '955 Isolation and determination of porphobilinogen Urine and tisv,es. Porphobilinogen was determined as described (Goldberg, 1954) . It was assumed that 1 mg. of porphobilinogen is equivalent to 130 Vahlquist (1939) units (Westall, 1952 (Goldberg & Rimington, 1954b) was confirmed in the present study. The blood haematocrit for the rat was taken to be 40 (Wintrobe, 1951) and plasma porphobilinogen was calculated on this basis. Paper chromatography. This was done as described by Westall (1952) and .
RESULTS
Intravenous injection of porphobilinogen Excretion pattern of porphobilinogen and porphyrins. Rats nos. 1 and 2 were given intravenous injections of 9-04 and 9-4 mg., respectively, of porphobilinogen after a preliminary period of 8 and 7 days, respectively, during which daily faecal and urinary porphyrins were determined. These determinations were continued during the succeeding 8 days. Porphobilinogen was rapidly excreted in the urine of both rats. It appeared in the urine within 10 min. of injection and was detectable until 8 hr. later. In rat no. 1 specimens of urine were collected every 2 hr. during the 12 hr. period after injection. The results of porphobilinogen, uroporphyrin and coproporphyrin determinations on these specimens are illustrated in Fig. 1 . This shows that nearly half of the total porphobilinogen excreted in the urine (6.07 mg.) was passed in the first 2 hr. after injection, while the excretion of the small quantities of uroporphyrin (4-59 ,ug.) and coproporphyrin (6.85 pg.) was more protracted.
A smaller yield of porphobilinogen was obtained in the urine of rat no. 2, viz. 2-85 mg., of which 2-6 mg. were excreted in the first 3 hr. after injection. This rat excreted a total of 4-95 ,ug. of uroporphyrin and 6-0 jug. of coproporphyrin in the 24 hr. following injection.
Paper chromatography of these porphyrins showed that they behaved as uroporphyrin III and coproporphyrin III, respectively. The porphobilinogen excreted in the urine was indistinguishable from crystalline porphobilinogen by paper chromatography, using butanol-acetic acid (Westall, 1952) . Furthermore, the lactam derivatives (Cookson of the porphobilinogen excreted in the urine and of crystalline porphobilinogen, behaved identically on a paper chromatogram. Table 1 summarizes the mean daily faecal coproporphyrin and protoporphyrin values before and after administration of porphobilinogen in rats nos. 1 and 2. These figures are similar in each rat. Paper chromatography of these porphyrins both before and after porphobilinogen administration demonstrated that some dicarboxylic porphyrin (similar in properties to protoporphyrin) as well as coproporphyrin had been extracted by 0.1N-HCI and thus the coproporphyrin determinations in Table 1 are too high. However, an amount of dicarboxylic porphyrin similar to that of coproporphyrin (as judged by fluorescence on paper chromatograms) was extracted by 0 1 N-HCl in each case. It was therefore considered that no significant change had occurred in faecal porphyrins as a result of porphobilinogen administration.
Neither rat showed any abnormal symptoms during the 8-day period following the porphobilinogen injection. Haemoglobin contents, red cell numbers and reticulocyte counts were determined in both rats, before and at the end of the experiment and one day before and one day after the injection. No significant changes in these haematological values were observed. Rats killed 20-25 hr. after half-hourly injections, maintained for 20 hr. In experimental porphyria in rats induced by allyli8opropylacetamide (Goldberg & Rimington, 1954b) , porphobilinogen is consistently found in the liver in high concentration, also in the kidney and urine, and sometimes in the plasma. This hepatic porphobilinogen could have been formed in the liver or at an extrahepatic site, e.g. the bone marrow, and transported by the blood stream to the liver. The very rapid excretion of porphobilinogen in the urine and the absence of porphobilinogen from the liver in the above experiments, when the plasma still contained porphobilinogen, made such an extrahepatic site unlikely. However, it was still possible that the liver might take up porphobilinogen from an extrahepatic site if porphobilinogen were present in the plasma for any length of time. To determine the approximate length of the period during which significant plasma levels are maintained in experimental porphyria, rat no. 12 was given allylheopropylacetamide by gastric intubation. Within 20 hr. this rat had excreted porphobilinogen in the urine. It was killed and porphobilinogen was found in the liver and kidney (Table 2) .
In order to mimic the effects of continuous production of porphobilinogen by a possible extrahepatic site throughout this period, 1 mg. of porphobilinogen was injected subcutaneously into rat no. 9 every 30 min. for 20 hr. The initial two doses were given together at the beginning of the experiment. Urinary excretion of porphobilinogen was determined hourly and urinary uroporphyrin and coproporphyrin, as well as plasma porphobilinogen were determined every 2 hr. (Fig. 2) . The rat was killed 15 min. after the final injection and tissues were analysed for porphobilinogen and porphyrins (Tables 2 and 3 ). The liver did not contain porphobilinogen, while the gut contents showed a significant amount of porphobilinogen, presumably from passage through the bile ducts. During the 20 hr. period of the experiment the rat showed no pathological symptoms.
Inspection of Fig. 2 shows that during the latter 10 hr. of this experiment the hourly urinary excretion levels of porphobilinogen were remarkably constant-a mean of 1530 ± 151 ,ug. weight. This figure is in good agreement with inulin clearance found in the rat (Smith, 1951) and would therefore suggest that porphobilinogen is filtered by the glomeruli and not reabsorbed to a significant extent. Table 3 summarizes the liver, kidney, and blood porphyrin determinations of rats nos. 4, 6, 7 and 9, which had been given porphobilinogen parenterally. There is no significant elevation of the porphyrin levels.
Enteral administration of porphobilinogen Excretion pattern of porphobilinogen and porphyrins. A study similar to that described for rats nos. 1 and 2, was carried out in rat no. 3. After a preliminary period of 6 days, 3-68 mg. of porphobilinogen were given by gastric intubation. Daily urinary and faecal porphobilinogen and porphyrin contents were determined during the base-line period and in the 7 days following porphobilinogen administration (Table 1) . There was no significant change in the porphyrin levels in the urine or faeces. No porphobilinogen appeared in the urine of this rat (cf. rats nos. 10 and 11, below), but 45 % of the porphobilinogen administered was recovered in the faeces. Traces of porphobilinogen were present in the faeces up to the sixth day after porphobilinogen administration. Rat kiUed after 7-5 hr. Rat no. 10 was given 3.4 mg. of porphobilinogen by gastric intubation.
Urinary porphobilinogen determinations were done every 30 min. (Fig. 3) . Porphobilinogen was detected in the urine within the second half-hour and was excreted in small amounts until 6 hr. after its administration. Maximum excretion in the urine occurred between 2 and 2-5 hr. Between 6 and 7.5 hr., when the rat was killed, no porphobilinogen was detected in the urine. After death 2-12 mg. of porphobilinogen was recovered from the intestinal contents. It was notable that in spite of this large quantity of porphobilinogen in the gut, it was not excreted in the urine in the last 1-5 hr. and this would suggest that porphobilinogen is only absorbed in the upper part of the rat intestine. Porphobilinogen was not found in the other tissues (Table 2) . Rat killed after 2 hr. Rat no. 11 was given 4-85 mg. of porphobilinogen by gastric intubation and killed 2 hr. later in order to see whether porphobilinogen could be detected in the liver during a phase of maximal absorption of porphobilinogen from the gut (see above). Urinary porphobilinogen determinations, as in rat no. 10, showed the excretion of 11-3, 30 and 46 jg. of porphobilinogen in the second, third and fourth half-hour periods, respectively, after administration. The rat was then killed and 1-75 mg. of porphobilinogen were recovered from the intestinal contents. The plasma contained 2-1 p.g. of porphobilinogen/ml., whilst 0-104 mg. of porphobilinogen was recovered from gut tissues after they had been thoroughly washed with normal saline. Porphobilinogen was not present in liver, kidney, muscle, fat, Harderian gland or brain (Table 2) . No porphyrins were detectable in the liver.
In vitro incubation of porphobilinogen with gastro-intestinal contents of a rat
This experiment was carried out to investigate further the absence of conversion of porphobilinogen into porphyrins in the gut, which was demonstrated in rat no. 3. A rat was killed and its gastro-intestinal contents were mixed with )BERG I955 sterile normal saline to give a total vol. of 23 ml. 4-5 ml. of this were pipetted into each of four 50 ml. conical flasks. Flasks nos. 1 and 2 were immersed in boiling water for 5 min. and 1 mg. of porphobilinogen in 0-56 ml. of sterile normal saline was added to flasks nos. 2 and 4. The pH of each of the contents of these flasks was about 6-6. The flasks were then plugged with cotton wool and incubated for 4 hr.
with shaking at 90-100 oscillations/min. at 37°. The contents were then analysed for porphobilinogen and porphyrins (Table 4) . The results show that a 59 and 52 % recovery of porphobilinogen was achieved from flasks nos. 2 and 4, but there was no significant change in the porphyrin content in any flask, with the exception of a small quantity of uroporphyrin (0.71 ,ug.) found in flask no. 2.
DISCUSSION
The results show that most of the porphobilinogen administered parenterally is excreted in the urine and that this excretion is rapid; small amounts, however, are recovered in the faeces. Given, however, by the enteral route, it is mainly excreted unchanged in the faeces, although small amounts, (in the case of rat no. 10, one-twentieth of the porphobilinogen given) may be excreted in the urine. The excretion behaviour of the naturally occurring porphyrins (uroporphyrin, coproporphyrin and protoporphyrin), after enteral and parenteral administration to experimental animals, has been studied previously. Fischer (1916) and Gunther (1922) found that uroporphyrin given parenterally to mice and rabbits, respectively, is mainly excreted in the urine, while Fischer (1915) found that uroporphyrin, when taken by himself by mouth, was passed unchanged in the stool. On the other hand, coproporphyrin III, given orally or parenterally to rats, is not passed in the urine, but recovered in the stool (Hoffbauer, Watson & Schwartz, 1953) . Protoporphyrin injected parentally into dogs with a bile-renal fistula was not accounted for in the porphyrins excreted thereafter, apart from traces of material resembling deuteroporphyrin (Watson, Pass & Schwartz, 1941) . The excretion of porphobilinogen thus resembles more that of uroporphyrin than that of coproporphyrin or protoporphyrin. The mean percentage recovery of the porphobilinogen administered, parenterally or enterally, was 53 ± 14. This compares with the 50 % recovery of coproporphyrin III injected parenterally into rats by Hoffbauer et al. (1953) . The absence of abnormal symptoms in any of the rats used in the present work confirms the results of the pharmacological study of porphobilinogen by Goldberg et at. (1954) . It is of some interest that a small, though significant, rise of coproporphyrin III occurred in the urine of rats nos. 1, 2 and 9, besides some excretion of uroporphyrin III. This is in accordance with the demonstration by Falk et al. (1953) using a haemolysed chicken erythrocyte system, that porphobilinogen is a precursor of uroporphyrin, coproporphyrin and protoporphyrin.
The site of the excessive porphobilinogen formation in acute porphyria is of importance. Prunty (1945) showed that porphobilinogen is found in high concentration in the liver at autopsy of these cases, and this observation has been repeatedly confirmed. Thus Schmid, Schwartz & Watson (1954) include this disease in their 'porphyria hepatica' group. Porphobilinogen is also found in the kidney and urine and sometimes in the bile and plasma, but not in other tissues. In experimental animals drugged with sedormid or allylisopropylacetamide, these same tissues also contain porphobilinogen and in the same relative concentrations. In fact Schmid & Schwartz (1952) refer to the experimental porphyria produced by sedormid as belonging to the 'hepatic type'. This suggested but did not prove, that in acute porphyria and in experimental porphyria ofanimals, porphobilinogen is formed in the liver. It did not exclude the possibility that porphobilinogen is formed at an extrahepatic site, e.g. the bone marrow, and is transported by the blood stream to the liver. The present experiments indicate that porphobilinogen is mainly excreted by glomerular filtration in the rat. Further, they show that porphobilinogen is not found in the liver after enteral or parenteral administration. The plasma porphobilinogen levels in these experiments were high, higher than thQse found in an attack of acute porphyria. In rat no. 9 this plasma level was maintained for 20 hr.,a period which had been found sufficient to induce an experimental porphyria by means of allyli8opropyl-acetamide, with accumulation of porphobilinogen in the liver in rat no. 12. These facts would suggest that extrahepatic porphobilinogen formation in experimental porphyria in the rat is improbable. It is also of interest that there was no significant increase of either coproporphyrin or protoporphyrin in the livers of rats given porphobilinogen. In the livers of patients with acute porphyria and of animals with experimental porphyria such an increase is present.
There is some evidence that the mechanism of porphobilinogen excretion in the rat may be relevant to human acute porphyria. In this disease, the high porphobilinogen concentrations in the urine and the persistently low concentrations in the plasma, even at the height of an attack, suggest a rapid excretion of that substance. Furthermore, a sharp rise of porphobilinogen excretion in the urine often accompanies and may even precede the onset of clinical symptoms of porphyria, which would also suggest rapid elimination. Finally, acute porphyria urine, which is freshly passed and has not lain in the bladder for long, contains mainly porphobilinogen with only traces of coproporphyrin and uroporphyrin. This is the same pattern of porphobilinogen and porphyrin excretion as is found in the urine of a rat, injected parenterally with porphobilinogen. A greater conversion of porphobilinogen into porphyrins would be expected, if porphobilinogen were not rapidly eliminated in acute porphyria. The probability of such a rapid elimination would explain the absence of photosensitivity in this disease, since this symptom is caused by an excessive amount of formed porphyrins in skin. These findings would suggest that the renal excretion of porphobilinogen in the rat is similar to that in human acute porphyria.* It has been pointed out that the porphobilinogen content of tissues in human acute porphyria and in experimental porphyria in animals is similar. This might suggest, in addition, that the reasoning put forward for a hepatic site of formation of porphobilinogen in the rat is valid for the human disease. SUMMARY 1. Porphobilinogen has been administered parenterally and enterally to rats. After parenteral injection, porphobilinogen was rapidly and mainly excreted in the urine. Small amounts were excreted in the faeces. After enteral administration, only small amounts were slowly excreted in the urine. Most of it was passed unchanged in the faeces. The porphobilinogen excreted in urine was identical chromatographically with that administered.
2. A calculation of renal clearance of porphobilinogen in the rat suggests that porphobilinogen is mainly excreted by glomerular filtration without significant reabsorption.
3. A small but significant rise of coproporphyrin III, as well as the excretion of some uroporphyrin III, was noted in rat urine after parenteral injection of porphobilinogen. There was no significant change in faecal porphyrin excretion after enteral or parenteral administration of porphobilinogen.
4. Aerobic incubation in vitro at 370 of porphobilinogen with gastro-intestinal contents of a rat * Note added in proof. Renal clearance studies recently done by the author in human acute and latent porphyria have shown that the endogenous porphobilinogen is excreted in man by glomerular filtration without significant reabsorption.
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A. GOLDBERG '955 showed no evidence of conversion of porphobilinogen into porphyrins.
5. Porphobilinogen was not found in the liver when rats were killed shortly after its enteral or parenteral administration, nor was it found in the liver of a rat after subcutaneous injections of porphobilinogen every half-hour for 20 hr., during which time a high plasma porphobilinogen concentration was maintained. These findings suggest that the porphobilinogen found in the liver of a rat with experimental porphyria is in fact formed there and is not transported by the blood stream to the liver from an extrahepatic site.
6. The relevance of these results, obtained in the rat, to human acute porphyria, is discussed.
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